Science

BBC NEWS      by Helen Briggs, Environment correspondent                                                                     Feb. 2, 2015

The devastation left by the Ebola virus in west Africa raises many questions for science, policy and international development.

One issue that has yet to receive widespread media attention is the handling of genetic data on the virus.

By studying its code, scientists can trace how Ebola leapt across borders, and how, like all viruses, it is constantly evolving and changing.

Yet, researchers have been privately complaining for months about the scarcity of genetic information about the virus that is entering the public domain.

In the last few days, scientists have been speaking on and off the record about their concerns.

http://www.bbc.com/news/science-environment-31091816

REUTERS by  Kate Kelland and Emma Farge                                                           Jan. 27, 2015

LONDON/DAKAR--A recent sharp drop in new Ebola infections in West Africa is prompting scientists to wonder whether the virus may be silently immunizing some people at the same time as brutally killing their neighbors.

So-called "asymptomatic" Ebola cases - in which someone is exposed to the virus, develops antibodies, but doesn't get sick or suffer symptoms - are hotly disputed among scientists, with some saying their existence is little more than a pipe dream.

NEW YORK TIMES by Andrew Pollack                               Jan. 23, 2015

As Ebola raged through West Africa last summer, an experimental drug was tried for the first time on two American aid workers in Liberia who were gravely ill with the virus. Both recovered, one of them rapidly.

Medicago, in North Carolina, is gearing up for possible production of the Ebola drug ZMapp using its plant-based technology. Credit Gerry Broome/Associated Press

Though it could not be said for sure that the drug, ZMapp, was responsible, patients and doctors began clamoring for it. But there was enough to treat only a handful of patients. Federal officials vowed to produce more.

MIT THE TECH  by Jennifer F. Switzer                         Jan. 14, 2015

CAMBRIDGE , MA-- At the Broad Institute of MIT and Harvard, in a lab run by accomplished computational geneticist Pardis Sabeti ’97, researchers have collaborated with institutions in the U.S. and abroad to sequence and analyze more than 99 Ebola virus genomes collected by fellow scientists in Sierra Leone. They are on the lookout for mutations that could aid in developing new treatment options for Ebola, or that could serve as indications that the virus is evolving to become more deadly.

Read complete story.
http://tech.mit.edu/V134/N62/ebola.htm